A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/567 (2006.01) A61P 5/34 (2006.01) A61P 5/36 (2006.01)
Patent
CA 2724030
The invention relates to a treatment regime and to combination preparations of 20,20,21,21,21 -pentafluoro-17-hydroxy-11 .beta.-[4- (hydroxyacetyl)phenyl]-19-nor-17a-pregna-4,9-diene-3-one of formula (I). Said invention relates to, in particular, a sequential regime for treating gynaecological diseases in which, in a first phase, the above-mentioned progesterone antagonist is administered and, in a second phase, a progestational hormone is administered.
L'invention concerne un traitement et des préparations combinées de 20,20,21,21,21-pentaflluoro-17-hydroxy-11ß-[4-hydroxyacétyl)phényl-19-nor-17a-pregna-4,9-diène-3-one représentées par la formule. Elle concerne, en particulier, un traitement séquentiel de troubles gynécologiques qui consiste à administrer, en une première phase, l'antagoniste de progestérone susmentionné et, en une deuxième phase, un progestatif.
Fuhrmann Ulrike
Moeller Carsten
Schwede Wolfgang
Bayer Schering Pharma Aktiengesellschaft
Fetherstonhaugh & Co.
LandOfFree
Sequential administration of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sequential administration of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sequential administration of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1705751